Cyclacel Pharmaceuticals CYCCP 深沪

已收盘 12-11 16:00:00 美东时间

10.50

+0.500

+5.00%

华盛通

立即下载

最高10.87
今开10.87
成交量 754股
最低 10.30
昨收 10.00
总市值 1.26亿
52周最高 22.13
市盈率 ^静 --
换手率 0.01%
52周最低 5.25
委比 -0.99%
总股本 1199.74万
历史最高 22.13
量比 0.55
振幅 5.70%
历史最低 -4.389
每手 1
风险率 2.88%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket

Shares of Guess?, Inc.

11-22 20:58
Cyclacel Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 EPS results.

Cyclacel Pharmaceuticals shares are trading lower after the company reported wo...

11-15 02:44
Earnings Scheduled For November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

11-13 19:40
Earnings Outlook For Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earn...

11-11 02:02
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Virios Therapeutics (NASDAQ:VIRI) stock increased by 49.4% to $0.77 d...

11-03 01:31
Cyclacel Pharmaceuticals Q2 EPS $(0.44) Beats $(0.50) Estimate, Sales $373.00K

Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.50) by 12 percent. This is a 4.35 percent increase over losses of $(0.46) per share

08-10 05:18
Cyclacel Pharmaceuticals's Earnings Outlook

Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earn...

08-09 01:01
奥本海默维持Cyclacel Pharmaceuticals"跑赢大盘 "建议

格隆汇5月26日丨Fintel报道，美国投资银行Oppenheimer维持对美国生物制药公司Cyclacel Pharmaceuticals(CYCC.US)的...

05-26 14:38
Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial Results

BERKELEY HEIGHTS, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceutica...

05-04 21:20
Cyclacel Pharmaceuticals Announces Receipt of $4.7M R&D Tax Credit

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced that it received a payment of £3.9 million ($4.7 million) as a research & development (R&D) tax credit from HMRC, the tax agency of the United Kingdom government.

05-03 21:16

派息除权日	每股总股息	派息日期
2023-10-19	0.15	2023-11-01
2023-07-20	0.15	2023-08-01
2023-04-20	0.15	2023-05-01
2023-01-12	0.15	2023-02-01
2022-10-13	0.15	2022-11-01
2022-07-14	0.15	2022-08-01
2022-04-13	0.15	2022-05-01
2022-01-13	0.15	2022-02-01
2021-10-14	0.15	2021-11-01
2021-07-15	0.15	2021-08-01
2021-04-15	0.15	2021-05-01
2021-01-14	0.15	2021-02-01
2020-10-15	0.15	2020-11-01
2020-07-16	0.15	2020-08-01
2020-04-14	0.15	2020-05-01
2020-01-16	0.15	2020-02-01
2019-10-10	0.15	2019-11-01
2019-07-11	0.15	2019-08-01
2019-04-12	0.15	2019-05-01
2019-01-11	0.15	2019-02-01
2018-10-12	0.15	2018-11-01
2018-07-12	0.15	2018-08-01
2018-04-10	0.15	2018-05-01
2018-01-11	0.15	2018-02-01
2017-10-12	0.15	2017-11-01
2017-07-12	0.15	2017-08-01
2017-04-11	0.15	2017-05-01
2017-01-13	0.15	2017-02-01
2016-10-13	0.15	2016-11-01
2016-07-13	0.15	2016-08-01
2016-04-14	0.15	2016-05-01
2016-01-19	0.15	2016-02-01
2015-10-21	0.15	2015-11-02
2015-07-15	0.15	2015-08-03
2015-04-15	0.15	2015-05-01
2014-12-31	0.15	2015-02-02
2014-06-27	0.15	2014-08-01
2014-04-15	0.15	2014-05-01
2014-01-15	0.15	2014-02-03
2013-10-17	0.15	2013-11-01
2013-07-18	0.15	2013-08-01
2013-04-17	0.15	2013-05-01
2013-01-17	0.15	2013-02-01
2011-04-19	0.15	2011-05-02
2011-01-19	0.15	2011-02-01
2009-01-14	0.15	2009-01-30
2008-10-16	0.15	2008-11-01
2008-07-16	0.15	2008-08-01
2008-04-16	0.15	2008-05-01
2008-01-16	0.15	2008-02-01
2007-10-17	0.15	2007-11-01
2007-07-18	0.15	2007-08-01
2007-04-18	0.15	2007-05-01
2007-01-18	0.15	2007-02-01
2006-10-19	0.15	2006-11-01
2006-07-20	0.15	2006-08-01
2006-04-26	0.15	2006-05-01
2006-01-18	0.15	2006-02-01
2005-10-19	0.15	2005-11-01
2005-07-20	0.15	2005-08-01
2005-04-20	0.15	2005-05-02
2005-01-19	0.15	2005-02-01

公司名称	Cyclacel Pharmaceuticals, Inc.
行业分类	Pharmaceuticals: Major
业务描述	Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Cyclacel Pharmaceuticals CYCCP 深 沪

10.50

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Cyclacel Pharmaceuticals CYCCP 深沪